PerkinElmer

Project Farma is a consulting firm that specializes in providing strategic and execution services to healthcare companies throughout the entire pharmaceutical and medical device supply chain. The firm focuses on biomanufacturing, offering expertise in capital projects, technology transfers, facility construction, strategy development, and regulatory compliance. By delivering tailored solutions, Project Farma assists clients in navigating the complexities of the healthcare industry, ensuring efficient operations and adherence to industry standards.

Covaris is a company focused on the development, manufacturing, and marketing of instruments, consumables, and reagents that facilitate pre-analytical sample preparation for genomic and proteomic analysis. Its product offerings include technologies such as instruments, kits, tubes, vials, and various accessories designed to enhance the efficiency and effectiveness of research in life sciences. By providing these essential tools, Covaris aims to support clients in making scientific discoveries, developing novel assays, and improving bioanalytical results, thereby accelerating advancements in research and innovation within the field.

Virtue Diagnostics (Suzhou) Co., Ltd. is an in vitro diagnostic (IVD) company based in Suzhou, China, with a research and development office in Singapore. Founded in 2019, the company specializes in developing advanced diagnostic platforms for the detection of infectious diseases, cancer, and chronic diseases. Its technology offerings include clinical mass spectrometry, multiplex immunohistochemistry for pathology-based cancer detection, and a molecular and immunoassay platform. Virtue Diagnostics aims to enhance diagnostic capabilities and improve patient outcomes through its innovative solutions.

BioLegend is a biotechnology company based in San Diego, California, that specializes in developing high-quality immunological reagents for biomedical research. The firm focuses on creating advanced antibodies, recombinant proteins, and bioassays, catering to a variety of scientific fields, including immunology, cancer research, and stem cell development. By providing a diverse array of reagents for applications such as flow cytometry and cell biology, BioLegend enables scientists to accelerate their research and discovery processes.

Sirion Biotech is a prominent company specializing in viral vector technology, which is essential for innovative therapeutics and gene modification in mammalian cells. Founded in 2007, the company has established itself as a leader in providing various viral vectors, including adenovirus, adeno-associated virus (AAV), and lentivirus, available in rapid turnaround times. Sirion's technology enables researchers to deliver genetic material into cells effectively, facilitating advancements in gene therapy and the development of new drug compounds. The company offers a comprehensive range of services, from particle production to virus-driven cell modeling, meeting the demands for preclinical, clinical, and animal testing. With a global presence in Munich, Tokyo, New Hampshire, and Tel Aviv, Sirion has successfully completed over 500 projects for both academic and industrial clients, demonstrating an annual growth rate of 70%. The business model includes flexible commercial arrangements, such as fee-for-service and licensing agreements, as the company continues to seek opportunities for further growth and technological advancement.

Immunodiagnostic Systems Holdings is a specialized company engaged in the development, manufacturing, and marketing of in-vitro diagnostic tests for clinical laboratories. Based in Boldon, United Kingdom, the company primarily serves markets in the UK, US, Germany, and France, among others. Its key offerings include a range of immunoassays and automated immunoanalyser technologies, notably the IDS-iSYS system, which utilizes chemiluminescence and absorbency technology for efficient and reliable immunoassay testing. The company focuses on various clinical areas, including bone and calcium metabolism, growth, hypertension, chronic kidney disease, autoimmunity, and infectious diseases. Established in 1977, Immunodiagnostic Systems Holdings aims to enhance diagnostic outcomes for patients through innovative automated and manual assays, ensuring both testing efficiency and quality in specialty immunoassay applications.

Nexcelom Bioscience LLC is a biotechnology company specializing in the development and marketing of image cytometry products for cell analysis utilized in life sciences and biomedical research. Founded in 2003 and based in Lawrence, Massachusetts, the company offers a range of products, including the Cellometer, which facilitates the counting and analysis of cell lines and primary cells through both bright field and fluorescence imaging, and the Celigo system, known for its high image quality and throughput capabilities for analyzing adherent and suspension cells in microwell plates. Nexcelom also provides a variety of fluorescent reagents and kits tailored for cell counting and cell-based assays, serving diverse research areas such as immuno-oncology, cell therapy, drug discovery, vaccine development, and therapeutic cell line generation.

Oxford Immunotec is a diagnostics company specializing in the development and commercialization of proprietary tests for immunology and infectious diseases. Headquartered in the UK, with operations in the US, the company's core technology, T-SPOT, measures specific T cell responses to inform diagnosis, prognosis, and monitoring of patients with immune-regulated conditions. Its flagship product, T-SPOT.TB, detects active and latent tuberculosis infection, while T-SPOT.CMV monitors cytomegalovirus in transplant recipients. Oxford Immunotec serves independent laboratories, hospital systems, and public and private institutions worldwide.

Carterra, Inc. is a biotechnology company specializing in label-free biomolecular interaction analysis solutions. Founded in 2005 and headquartered in Salt Lake City, Utah, Carterra offers a range of products and services that facilitate multiplexing on planar array surfaces. Its flagship technologies include the MultipleX 96, an array-based surface plasmon resonance (SPR) imaging system, and the Continuous Flow Microspotter (CFM), a microarray printer that employs flow for efficient sample deposition. The company's offerings extend to contract research services, which cover high-throughput epitope binning and mapping, first-pass kinetics, and assay development. Additionally, Carterra provides a variety of supporting solutions, such as maintenance solutions, kits, and running buffers. These products are utilized in various applications, including kinetics software, epitope software, and antibody format development. Carterra also operates additional offices in Dublin, California; Andover, Massachusetts; and Munich, Germany, and sells its products through distributors in China and Japan, as well as online.

Horizon Discovery Group plc is a UK-based life science company specializing in gene editing and gene modulation technologies that advance research and clinical applications in human health. Established in 2007 and headquartered in Cambridge, the company designs, manufactures, and applies a wide array of gene editing tools, including custom-made and off-the-shelf RNA interference (RNAi) reagents, CRISPR reagents, and various cell models. Horizon Discovery offers services such as pooled and arrayed CRISPR screens, drug screens, and immunology assays, catering to the needs of academic research labs, biopharmaceutical companies, and contract research organizations. Its extensive product catalog includes over 1,000,000 cell and reagent products that help scientists investigate genetic anomalies associated with diseases like cancer. The company has formed strategic partnerships with various institutions to enhance its offerings, including collaborations for developing innovative gene editing technologies. As of December 2020, Horizon operates as a subsidiary of PerkinElmer (UK) Holdings Ltd.

Cisbio Bioassays, a life sciences company, develops various assays and reagents for pharmaceutical, biotechnology, academia, and contract research organizations worldwide. It offers G-protein coupled receptor (GPCR), a homogeneous time-resolved fluorescence (HTRF) cellular platform solution; kinases and cell signaling solutions, such as assays for covering various needs for monitoring kinase targets; and a line of HTRF epigenetic toolbox reagents and kits for high throughput screening and investigation of epigenetic targets.

SSI is one of the manufacturers of analytical instruments in China. SSI delivers analytical solutions and services to a wide range of research, academic, government, pharmaceutical, industrial, life sciences and chemical analysis laboratories. Its portfolio includes photoelectric colorimeters, UV-Vis spectrophotometers, atomic absorption spectrophotometers and accessories.

RHS Limited is a biotechnology company based in Thebarton, Australia, specializing in the development and marketing of advanced genetic solutions. Founded in 1980, RHS focuses on products that enhance preimplantation genetic testing, including its lead offerings such as EmbryoCellect, a preimplantation genetic screening solution, and DOPlify, a whole genome amplification kit. The company also provides services related to preimplantation genetic screening and whole genome amplification. Through its innovative technologies, RHS aims to improve health and research outcomes by facilitating the detection of chromosomal abnormalities in fetal DNA, thereby supporting medical companies in their genetic testing efforts. In June 2017, RHS Limited changed its name from Reproductive Health Science Limited and operates as a subsidiary of PerkinElmer, Inc.

EUROIMMUN AG develops and manufactures medical laboratory reagents for the diagnosis of autoimmune and infectious diseases and allergies. It offers indications for autoimmunity, infections, allergology, antigen detection, and molecular diagnostics; autoimmunity products for rheumatology, hepatology, gastroenterology, endocrinology, neurology, nephrology, dermatology, and infertility; and infection products for immunity determination, CSF diagnostics, emerging viruses, avidity, BIOCHIP Mosaics for infectious serology, and others, as well as additional reagents for determination of acute infections.

Tulip Diagnostics is a company that specializes in the manufacturing of in-vitro diagnostic reagents, kits, and instruments. It focuses on the research, development, and design of systems and platforms for diagnostic applications. The company is dedicated to creating indigenous semi-automated and automated analyzers, enhancing the capabilities of diagnostic testing. With a commitment to innovation in the field of diagnostics, Tulip Diagnostics aims to provide high-quality solutions that meet the evolving needs of healthcare providers.

Vanadis Diagnostics, AB is a company based in Sollentuna, Sweden, specializing in non-invasive prenatal testing (NIPT) solutions. The company focuses on developing the Vanadis Smart NIPT platform, which utilizes digital analysis of cell-free DNA to provide reliable and accurate screenings for trisomies 21, 18, and 13. By eliminating the need for complex DNA amplification and analysis, Vanadis aims to simplify the screening process for healthcare providers, thereby enhancing access to high-performance trisomy screening for pregnant women. Vanadis Diagnostics operates as a subsidiary of Perten Instruments AB.

Ceiba Solutions develops informatics platforms and offers managed services to life sciences and health care industries.

Shanghai Haoyuan Biotech Co., Ltd. specializes in the research and development of diagnostic technologies aimed at detecting infectious diseases. The company provides molecular infectious disease screening solutions tailored for blood banks and clinical laboratories across China. By incorporating advanced nucleic acid detection technology, Haoyuan enhances the capabilities of healthcare facilities in identifying various infectious diseases. Additionally, the company has expanded its offerings by including four infectious disease assays that have received approval from China's State Food and Drug Administration, thereby reinforcing its commitment to improving public health through innovative diagnostic tools.

Caliper Life Sciences, Inc. is a provider of products and services tailored for pharmaceutical and biotechnology companies, as well as government and nonprofit research institutions. The company specializes in integrated systems that encompass instruments, software, reagents, and laboratory automation tools, aimed at enhancing the drug discovery and development process. Its offerings include advanced technologies for molecular imaging, microfluidics, and liquid handling, which address critical challenges in research. Notable products include IVIS Imaging Systems for optical molecular imaging, LabChip systems for drug discovery that enhance data accuracy, and automated liquid handling instruments such as the Caliper Sciclone. Additionally, Caliper provides contract research services, transgenic animal services, and comprehensive support for drug discovery. Founded in 1995 and headquartered in Hopkinton, Massachusetts, Caliper Life Sciences sells its products through a dedicated sales force and a network of distributors, helping researchers streamline their workflows and improve the efficiency of preclinical studies.

Dexela is a company focused on developing advanced 3-D breast imaging technology aimed at the early detection of breast cancer. It offers a range of products, including the DexTop Digital Mammography Workstation, which enhances screening workflow and performance, and a 3D reconstruction engine provided to original equipment manufacturer (OEM) partners under licensing agreements. The company manufactures flat panel CMOS X-ray detectors utilized in various medical applications, such as mammography, tomosynthesis, breast CT, and dental imaging, as well as in scientific and non-destructive testing applications. In addition to its product offerings, Dexela provides consulting services related to digital tomosynthesis and optimal 3D data reconstruction. Founded in 2003 and headquartered in London, the company also maintains an X-ray research and development facility in Sudbury, Massachusetts.

Labtronics Inc is a leading provider of data integration solutions tailored for laboratories across various industries. The company specializes in instrument integration and workflow automation, enabling it to deliver innovative solutions that address the complex demands of modern laboratory environments. Among its key offerings are the Nexxis ELN, an electronic laboratory notebook designed for quality control, and the Nexxis iLAB laboratory automation platform. Through these products, Labtronics aims to enhance efficiency and accuracy in laboratory procedures, supporting laboratories in their routine analysis and operational needs.

Geospiza Inc. is a software development company specializing in workflow management for genetic analysis. Founded in 1997 and headquartered in Seattle, Washington, Geospiza provides solutions such as GeneSifter Analysis Edition, a cloud-based platform for analyzing microarray and sequencing data, and GeneSifter Lab Edition, which supports laboratory workflows. The company caters to the laboratory, data management, and analytical requirements of various clients, including biotechnology and pharmaceutical companies, universities, researchers, and diagnostic laboratories engaged in genetic testing and biotherapeutics manufacturing.

ArtusLabs specializes in developing collaborative software platforms for life science researchers. Their flagship product, Ensemble for Life Science, combines social networking, collaboration tools, and advanced data mining to facilitate internal and external research communication and management. This platform includes an Electronic Lab Notebook feature that enables users to capture experimental data and results, supporting medicinal chemists, biologists, and bio-analytical departments. ArtusLabs aims to accelerate drug discovery by enhancing workplace collaboration and improving scientific data management. The company's team has extensive experience in handling complex scientific data and maintains close relationships with global researchers.

CambridgeSoft Corporation is a prominent provider of software and solutions tailored for the pharmaceutical, biotechnology, and chemical industries. The company specializes in offering enterprise solutions, desktop software, scientific databases, and consulting services that facilitate the discovery and collaboration of scientific knowledge. Its flagship product, Chem & Bio Office, serves as a critical communication tool for chemists, allowing them to effectively create, analyze, and share chemical and biological information. Additionally, the enterprise version, Chem & Bio Office Enterprise, supports organizations in deploying comprehensive research information solutions through various digital technologies. CambridgeSoft's products are widely utilized across the pharmaceutical and biotechnology sectors, as well as in academic and government research settings, enhancing the efficiency and effectiveness of scientific communication and discovery processes.

chemagen is a key player in the field of automated nucleic acid isolation. The purification of DNA, RNA, or viral DNA/RNA is facilitated through chemagen’s proprietary M-PVA Magnetic Bead technology.

VisEn Medical is a company that specializes in the design, development, and commercialization of fluorescence in vivo imaging technology platforms. Their Fluorescence Molecular Tomographic (FMT) imaging systems and associated imaging agents are used to identify, characterize, and quantify disease biomarkers and assess therapeutic efficacy within living organisms. Additionally, VisEn Medical offers specific imaging agents such as ReninSense680 for monitoring hypertension and renal disease biomarkers, and VivoTagR 680 XL fluorescent dye for labeling biomolecules in various imaging applications. The company also provides fluorescence tomographic imaging systems to support these technologies.

Signature Genomic Laboratories is a Spokane, Washington-based provider of molecular cytogenetic diagnostic services. The company specializes in a range of diagnostic offerings, including pediatric and adult testing, as well as prenatal services. It employs advanced techniques such as FISH analysis for clinically relevant loci and provides comprehensive prenatal diagnosis services. Additionally, Signature Genomic Laboratories offers interpretation of genome microarrays and G-banded karyotype analysis, catering to the needs of healthcare professionals and patients seeking precise genetic insights.

SYM-BIO Lifescience, a leading provider of diagnostics instruments and related reagents.

Surendra Genetic Labs, Pvt. Ltd. provides testing services for pregnant mothers and newborns. The company operates as laboratory, which focuses on fetal, maternal, and newborn health.

Analytica of Branford, Inc. develops and markets electrospray ion sources for mass spectrometry.

Opto Technology Inc. specializes in the design, development, and manufacture of optoelectronic and light-emitting diode (LED) products. The company produces a diverse range of LED-related products tailored for various sectors, including analytical instrumentation, medical and dental lighting, transportation, industrial applications, and architectural lighting solutions. Through its innovative approach, Opto Technology aims to meet the specific needs of these industries, providing advanced lighting solutions that enhance performance and efficiency.

rnel Inc., a recognized leader in custom engineered solutions for gas chromatography applications in the petrochemical, food and beverage, and industrial hygiene markets. The acquisitionis an important strategic initiative to expand PerkinElmer's chromatography portfolio and strengthen its application-focused expertise to best serve the biofuels and hydrocarbon processing industries.

LabMetrix Technologies, Inc. provides metrology-based multi-vendor analytical instrument qualification solutions.

Pediatrix's screening reference laboratory and its StepOne® newborn screening product, which is capable of analyzing more than 50 inherited disorders in newborns, to its genetic screening product offerings. The laboratory provides neonatal screening and consultative services to five states and the District of Columbia, as well as to hospitals and medical groups.

ViaCell is a biotechnology company focused on the area of women’s health. The company develops ViaCord, which enables families preserve their baby’s umbilical cord blood at the time of birth for possible future medical use; and ViaCyte, to broaden reproductive choices for women through the cryopreservation of human unfertilized eggs. ViaCell is based in Boston, Massachusetts.

Applied Biosystems is a prominent provider of innovative instruments, reagents, and software designed to enhance academic and clinical research, drug discovery, and various analytical applications. The company specializes in technology solutions for the analysis of DNA, RNA, proteins, and small molecules. Its offerings include instrument-based systems and consumables, along with comprehensive field application support services for genetic and protein analysis. Applied Biosystems plays a critical role in advancing research capabilities in areas such as pathogen detection, environmental analysis, and forensic DNA analysis, positioning itself as a key player in the life sciences sector.